Pfizer (PFE) announced that its board of directors declared an increase in the quarterly cash dividend on the company’s common stock to 43c for the first-quarter 2025 dividend, payable March 7, 2025, to holders of the Common Stock of record at the close of business on January 24, 2025. The first-quarter 2025 cash dividend will be the 345th consecutive quarterly dividend paid by Pfizer.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PFE:
- Pfizer announces results from PATINA trial
- Notable open interest changes for December 11th
- Pfizer price target lowered to $33 from $35 at Guggenheim
- Relay Therapeutics reports updated interim clinical data for RLY-2608
- eBay downgraded, GM upgraded: Wall Street’s top analyst calls
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
